FI  Clarke Capital Partners

http://clarkecp.com





     Office Locations:

3 Columbus Circle 15th Floor
New York, NY 10019

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Growth


 

Industries:

  • Consumer Products & Services
  • Information Technology
  • Real Estate & Construction

  •  

    Description:

    Clarke Capital is a Family Office Investment Firm, focused on Alternative Assets, Hedge Funds, Early Stage University-Licensed/Acquired Technologies and Growth Equity. The firm invests in growing companies, normally producing $1-$5 MM of EBITDA with excellent management teams and defensible business strategies through Private Placements, Debt Instruments and Institutional Grade Alternatives. Portfolio companies have an established presence on the Eastern U.S. coast and throughout Europe and Asia. James Clarke is the CEO of Clarke Capital Partners. In 2001, James Clarke founded and led Utah-based CLEARLINK- with over 1,800 full-time employees today--until it was acquired in 2011 by Pamlico Capital (formerly Wachovia) and has since been acquired in 2016 by Sykes (NSDQ:SYKE). Clarke serves as chair or director on the boards of various private and public companies in the U.S. and abroad, including the 2017 upsized IPO of PetIQ (NSDQ:PetQ) which was 12 times oversubscribed and traded up nearly 50% upon its debut to public markets. He has also served as a trustee and board member of several universities as well as regional and global non-profit organizations. Currently, James is a Governor appointed Trustee at Utah Valley University--the state's largest institution of higher learning with over 37,000 full-time students--where he serves as Chairman of the Foundation Board.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    James Clarke Founder and CEO
    James Harrison President
    Tara Rosander Operating Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/29/2023


      Biolexis Therapeutics


      UT


      $10,000,000


      Series A


     

    Portfolio companies include:

     

    Recent News: